TRAF3IP2 and breast cancer: Here, we present evidence demonstrating that ACT1-mediated augmentation of Cx43-composed gap junctions impairs proliferation or induces apoptosis in breast cancer cells but not in non-transformed mammary epithelial cells, confirming a tumor suppressive function for Cx43.